Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-027740
Filing Date
2025-02-26
Accepted
2025-02-26 16:10:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 13751
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 74230
  Complete submission text file 0000950170-25-027740.txt   118001
Mailing Address 95 SOUTH STATE STREET SUITE 2190 SALT LAKE CITY UT 84111
Business Address 95 SOUTH STATE STREET SUITE 2190 SALT LAKE CITY UT 84111 801-961-1599
Leavitt Equity Partners III, L.P. (Filed by) CIK: 0001883023 (see all company filings)

EIN.: 872495064 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 11 HURON DR STE 200 NATICK MA 01760
Business Address 11 HURON DR STE 200 NATICK MA 01760 508-647-4000
ALLURION TECHNOLOGIES, INC. (Subject) CIK: 0001964979 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94138 | Film No.: 25670117
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)